Date: July 12, 2023 | Time: 1:00 PM - 2:00 PM EDT
Enforcement of USP Chapters 795, 797, and 800 is less than six months away. In a recent survey, only 31% of pharmacies are ready for full compliance with the 2023 USP <797> reference standards.
As the November 1st deadline looms, our customers have been asking questions in key categories as they struggle to interpret the new standards. How are you addressing the changes to the following areas?
1. Personnel training & competencies
2. Environmental Monitoring
3. Scope and Beyond-use Dates
Our Pharmacy compliance experts, Annie Lambert, PharmD, BCSCP and Jennifer Smith, PharmD, BCSCP, will provide some answers and bring clarity to key changes with the 2023 USP reference standard updates. Join us to gain insights and practical strategies as you prepare for implementation.
Learning objectives:
Describe core skills, training and competency requirements and expected documentation for USP 795, 797, and 800.
Summarize requirements for a sterile compounding environmental monitoring program and prioritize actions for implementation.
Evaluate impacts to your pharmacy operations based on revised scope and beyond-use dates for sterile and nonsterile compounded preparations.
Simplifi 797 is a customizable, expert-developed automated solution that takes the effort out of USP <795>, <797>, and <800> compliance. Optimize your operations and pass inspections with the only closed-loop compliance support on the market. More than 2,000 pharmacies trust Simplifi 797 for compounding compliance confidence. Wolters Kluwer provides trusted clinical technology and evidence-based solutions that drive effective outcomes across healthcare. Specialized in clinical effectiveness, learning, research, and safety.
